Market Overview

UPDATE: Morgan Stanley Reiterates On Walgreen Company As Inversion Debate Continues

Share:
Related WAG
Where Are People Using Apple Pay?
Early Global News: Record Online Sales, 400% Jump In Tinder Users, China Experiences Worst Drop In Months

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company (NYSE: WAG), but removed the $75.00 price target.

In the report, Morgan Stanley noted, “Political debate intensifying around high profile tax inversion deals adding to the uncertainty around the plausibility of inversion for WAG. While prospects for inversion have been a key debate for WAG shares, we see opportunities for the combined WAG/AB to lower tax rate and expand margins independent of a corporate inversion.”

Walgreen Company closed on Friday at $68.66.

Latest Ratings for WAG

DateFirmActionFromTo
Dec 2014JP MorganMaintainsOverweight
Dec 2014BarclaysMaintainsEqual-weight
Dec 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for WAG
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (WAG)

View Comments and Join the Discussion!